ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 282

The Value of Imaging As an Early Noninvasive Test for Prosthetic Joint Septic Arthritis

Kevin Byrne1, Mary Louise Fowler2, Sarah Lieber3, Robert Shmerling4 and Ziv Paz3, 1Boston University School of Medicine, Boston, MA, 22Boston University School of Medicine, Boston, MA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Infection, orthopaedic, prosthesis, radiology and surgery

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

 

Background/Purpose: Medical imaging is commonly obtained in evaluating patients with suspected prosthetic joint septic arthritis (PJSA); it may be helpful to detect other pathology in the joint (e.g., chondrocalcinosis), to establish a baseline, or to detect the presence of synovial fluid. Imaging may even help diagnose PJSA, but there is little data available to evaluate the value of various imaging modalities for the diagnosis of PJSA.

 

Objectives: To examine how the use of medical imaging for PJSA has changed over the 17 years of this study and to assess the value of different imaging modalities in differentiating patients with culture-positive PJSA from patients with culture-negative PJSA.

 

Methods: We conducted a retrospective study that included all patients ages 18 years and older who were diagnosed with monoarticular  PJSA and underwent surgical intervention at a single, tertiary-care hospital between 1997 and 2014.

 

Results: Of the 280 patients with diagnosed PJSA, 214 (76.4%) had at least one imaging study during the index admission. Radiographs were performed in 167 patients (59.6%). The second most common imaging modality was CT scan (17 patients; 6.1%). The most common imaging findings were joint effusion in 91 (32.5%) patients and soft tissue swelling in 41 (14.6%) patients.  Of the 280 patients assigned a diagnosis of PJSA, 190 (69.3%) were culture-positive. Patients with culture-positive PJSA were less likely to have normal findings in their plain radiographs (3.7 vs. 13.1%, p=0.007), more likely to have gas/free air (7.4 vs. 1.2%, p=0.043), but no more likely to have joint effusions (28.9 vs. 25.0%, p=0.56) or soft tissue swelling (13.2 vs. 8.3%, p=0.31). The percentage of patients receiving each imaging modality remained relatively constant over the course of the study (Figure 1).

Conclusion: Imaging studies—especially radiographs—are commonly ordered to evaluate patients with suspected PJSA. Our study demonstrates that patients with culture negative PJSA are more likely to have normal findings on imaging, including radiographs. Patients with culture-positive PJSA were significantly more likely to have radiographic findings of gas or free air. Imaging studies in general and radiographs in particular demonstrated joint effusions in patients at similar rates among PJSA patients with and without positive cultures. This study demonstrates that in most cases imaging studies have limited utility among patients with suspected PJSA and cannot be relied upon to demonstrate specific findings to suggest the diagnosis.

Figure 1: Trend over time for the percentage of patients receiving different modalities of imaging studies. The line labeled “Overall” indicates the percentage of patients receiving any form of imaging study.


Disclosure: K. Byrne, None; M. L. Fowler, None; S. Lieber, None; R. Shmerling, None; Z. Paz, None.

To cite this abstract in AMA style:

Byrne K, Fowler ML, Lieber S, Shmerling R, Paz Z. The Value of Imaging As an Early Noninvasive Test for Prosthetic Joint Septic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-value-of-imaging-as-an-early-noninvasive-test-for-prosthetic-joint-septic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-value-of-imaging-as-an-early-noninvasive-test-for-prosthetic-joint-septic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology